Back to Search

A Phase II Trial Evaluating APX005M (a CD40 Agonistic Monoclonal Antibody) in Combination With Standard-of-Care Doxorubicin for the Treatment of Advanced Sarcomas


  • Protocol Number: 202107082
  • Principal Investigator: Weiss, Mia
  • Cancer Types: Sarcoma

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions